Park Avenue Institutional Advisers LLC 13F Portfolio

CIK 1640801 Filing since Q2 2015 Q1 2026 filed May 1, 2026
Holdings as of Mar 31, 2026, from the 13F filed May 1, 2026.

Portfolio Snapshot

3 positions · Q1 2026

Park Avenue Institutional Advisers LLC reported 3 positions worth $882.29K for the quarter ended Mar 31, 2026, down 12.3% on the prior quarter. It opened 0 new positions, added to 0, trimmed 0 and exited 0. Its largest holding is Revolution Medicines, Inc. at 56.4% of the portfolio.

Portfolio Value
$882.29K
-12.3% QoQ · — YoY
Positions
3
0 new · 0 sold out
Top 10 Concentration
100%
of portfolio value
Largest Position
RVMD 56.4%
Revolution Medicines, Inc.
Net Buying
$0.00
$0.00 bought · $0.00 sold
Turnover
0%
of the portfolio traded
Top Sector
Healthcare
56.4% of value
Track Record
35
quarters on file since Q2 2015

Portfolio Value & Positions

Value Positions

Reported 13F market value at each quarter end. A change mixes trading with price moves in the positions held.

Showing the last 8 quarters Subscribers see the full history since Q2 2015.

Sector Allocation

2 sectors
56.38%
Healthcare

Quarterly Buying & Selling

Bought Sold

Dollar value of shares bought and sold each quarter, at that quarter’s price. It counts trading only, not price changes.

Position Changes

How many positions were opened, added to, trimmed or closed each quarter.

Showing the last 8 quarters Subscribers see the full history since Q2 2015.

Sector Allocation Over Time

Share of reported value in each sector at every quarter end.

Showing the last 8 quarters Subscribers see the full history since Q2 2015.

Largest Buys

Q1 2026

No positions were added to this quarter.

Largest Sells

Q1 2026

No positions were reduced this quarter.

New Positions

Q1 2026

No new positions this quarter.

Closed Positions

Q1 2026

No positions were closed this quarter.

Holdings · Q1 2026

3 Positions

As ofMar 31, 2026
Value$882.29K
Top 10100%
Avg position$294.10K
# Activity
Showing all 3 positions 13F filings on SEC EDGAR

Tip. Select a row to see that position’s full history at Park Avenue Institutional Advisers.

About Park Avenue Institutional Advisers LLC’s 13F Portfolio

What are Park Avenue Institutional Advisers LLC’s largest holdings?

As of its Q1 2026 13F filing, Park Avenue Institutional Advisers LLC’s five largest positions were Revolution Medicines, Inc. (RVMD) at 56.4%, Braze, Inc. (BRZE) at 23.8%, ServiceTitan, Inc. (TTAN) at 19.8% of the reported portfolio.

How much is Park Avenue Institutional Advisers LLC’s portfolio worth?

Park Avenue Institutional Advisers LLC reported a 13F portfolio worth $882.29K across 3 positions for Q1 2026. That is down 12.3% from the previous quarter.

Where does this data come from?

From the Form 13F-HR reports Park Avenue Institutional Advisers LLC files with the SEC each quarter, within 45 days of quarter end. A 13F lists long positions in US-listed equities and options; it excludes short positions, cash, bonds and most non-US holdings.

Similar-Sized Institutions

by reported 13F value

13F data reflects long positions in US-listed equities and options as reported to the SEC up to 45 days after quarter end. It excludes short positions, cash, bonds and most non-US securities, so it is not a complete picture of a manager’s assets.